Lycopene and the LXRα agonist T0901317 synergistically inhibit the proliferation of androgen-independent prostate cancer cells via the PPARγ-LXRα-ABCA1 pathway

Journal of Nutritional Biochemistry

Volumn 23, Issue 9, 2012, Pages 1155-1162

  Yang, Chih Min ^a   Lu, Ya Ling ^a   Chen, Huei Yan ^a   Hu, Miao Lin ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

ABCA1; LXR ; Lycopene; PPAR ; Prostate cancer

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; ABC TRANSPORTER A1; LIVER X RECEPTOR ALPHA; LYCOPENE; MESSENGER RNA; N (2,2,2 TRIFLUOROETHYL) N [4 [2,2,2 TRIFLUORO 1 HYDROXY 1 (TRIFLUOROMETHOXY)ETHYL]PHENYL]BENZENESULFONAMIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL; CELL PROLIFERATION; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DRUG POTENTIATION; GENE SILENCING; INHIBITION KINETICS; PROSTATE CANCER; PROTEIN EXPRESSION;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ATP-BINDING CASSETTE TRANSPORTERS; CAROTENOIDS; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLESTEROL; DIETARY SUPPLEMENTS; FOOD-DRUG INTERACTIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROCARBONS, FLUORINATED; MALE; NEOPLASM PROTEINS; ORPHAN NUCLEAR RECEPTORS; OSMOLAR CONCENTRATION; PPAR GAMMA; PROSTATIC NEOPLASMS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SULFONAMIDES;

EID: 84865090847     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.06.009     Document Type: Article

References (51)

1. Cancer facts & figures 2010 2010, American Cancer Society, American Cancer Society, Atlanta.
2. Crawford E.D. Understanding the epidemiology, natural history, and key pathways involved in prostate cancer. Urology 2009, 73:S4-10.
3. Chuu C.P., Kokontis J.M., Hiipakka R.A., Liao S. Modulation of liver X receptor signaling as novel therapy for prostate cancer. J Biomed Sci 2007, 14:543-553.
4. Kaighn M.E., Narayan K.S., Ohnuki Y., Lechner J.F., Jones L.W. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 1979, 17:16-23.
5. Stone K.R., Mickey D.D., Wunderli H., Mickey G.H., Paulson D.F. Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer 1978, 21:274-281.
6. Olson J.A., Krinsky N.I. Introduction: the colorful, fascinating world of the carotenoids: important physiologic modulators. FASEB J 1995, 9:1547-1550.
7. van Breemen R.B., Pajkovic N. Multitargeted therapy of cancer by lycopene. Cancer Lett 2008, 269:339-351.
8. Stahl W., Sies H. Lycopene: a biologically important carotenoid for humans?. Arch Biochem Biophys 1996, 336:1-9.
9. Clinton S.K. Lycopene: chemistry, biology, and implications for human health and disease. Nutr Rev 1998, 56:35-51.
10. Gerster H. The potential role of lycopene for human health. J Am Coll Nutr 1997, 16:109-126.
11. Huang C.S., Liao J.W., Hu M.L. Lycopene inhibits experimental metastasis of human hepatoma SK-Hep-1 cells in athymic nude mice. J Nutr 2008, 138:538-543.
12. Huang C.S., Fan Y.E., Lin C.Y., Hu M.L. Lycopene inhibits matrix metalloproteinase-9 expression and down-regulates the binding activity of nuclear factor-kappa B and stimulatory protein-1. J Nutr Biochem 2007, 18:449-456.
13. Huang C.S., Shih M.K., Chuang C.H., Hu M.L. Lycopene inhibits cell migration and invasion and upregulates Nm23-H1 in a highly invasive hepatocarcinoma, SK-Hep-1 cells. J Nutr 2005, 135:2119-2123.
14. Kanagaraj P., Vijayababu M.R., Ravisankar B., Anbalagan J., Aruldhas M.M., Arunakaran J. Effect of lycopene on insulin-like growth factor-I, IGF binding protein-3 and IGF type-I receptor in prostate cancer cells. J Cancer Res Clin Oncol 2007, 133:351-359.
15. Ivanov N.I., Cowell S.P., Brown P., Rennie P.S., Guns E.S., Cox M.E. Lycopene differentially induces quiescence and apoptosis in androgen-responsive and -independent prostate cancer cell lines. Clin Nutr 2007, 26:252-263.
16. Ford N.A., Elsen A.C., Zuniga K., Lindshield B.L., Erdman J.W. Lycopene and apo-12'-lycopenal reduce cell proliferation and alter cell cycle progression in human prostate cancer cells. Nutr Cancer 2011, 63:256-263.
17. Tang L., Jin T., Zeng X., Wang J.S. Lycopene inhibits the growth of human androgen-independent prostate cancer cells in vitro and in BALB/c nude mice. J Nutr 2005, 135:287-290.
18. Limpens J., Schröder F.H., de Ridder C.M., Bolder C.A., Wildhagen M.F., Obermüller-Jevic U.C., et al. Combined lycopene and vitamin E treatment suppresses the growth of PC-346C human prostate cancer cells in nude mice. J Nutr 2006, 136:1287-1293.
19. Yang C.M., Yen Y.T., Huang C.S., Hu M.L. Growth inhibitory efficacy of lycopene and beta-carotene against androgen-independent prostate tumor cells xenografted in nude mice. Mol Nutr Food Res 2010, 55:606-612.
20. Palozza P., Colangelo M., Simone R., Catalano A., Boninsegna A., Lanza P., et al. Lycopene induces cell growth inhibition by altering mevalonate pathway and Ras signaling in cancer cell lines. Carcinogenesis 2010, 31:1813-1821.
21. Kliewer S.A., Lehmann J.M., Willson T.M. Orphan nuclear receptors: shifting endocrinology into reverse. Science 1999, 284:757-760.
22. Li A.C., Glass C.K. PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis. J Lipid Res 2004, 45:2161-2173.
23. Mueller E., Smith M., Sarraf P., Kroll T., Aiyer A., Kaufman D.S., et al. Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer. Proc Natl Acad Sci U S A 2000, 97:10990-10995.
24. Tsubouchi Y., Sano H., Kawahito Y., Mukai S., Yamada R., Kohno M., et al. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis. Biochem Biophys Res Commun 2000, 270:400-405.
25. Matsuyama M., Yoshimura R. Peroxisome proliferator-activated receptor-gamma is a potent target for prevention and treatment in human prostate and testicular cancer. PPAR Res 2008, 2008:249849.
26. Joseph S.B., Tontonoz P. LXRs: new therapeutic targets in atherosclerosis?. Curr Opin Pharmacol 2003, 3:192-197.
27. Song C., Kokontis J.M., Hiipakka R.A., Liao S. Ubiquitous receptor: a receptor that modulates gene activation by retinoic acid and thyroid hormone receptors. Proc Natl Acad Sci U S A 1994, 91:10809-10813.
28. Fukuchi J., Kokontis J.M., Hiipakka R.A., Chuu C.P., Liao S. Antiproliferative effect of liver X receptor agonists on LNCaP human prostate cancer cells. Cancer Res 2004, 64:7686-7689.
29. Campbell J.K., Stroud C.K., Nakamura M.T., Lila M.A., Erdman J.W. Serum testosterone is reduced following short-term phytofluene, lycopene, or tomato powder consumption in F344 rats. J Nutr 2006, 136:2813-2819.
30. Yang CM, Lu IH, Chen HY, Hu ML. Lycopene inhibits the proliferation of androgen-dependent human prostate tumor cells through activation of PPARγ-LXRα-ABCA1 pathway. J Nutr Biochem. [Epub ahead of press]. doi:10.1016/j.jnutbio.2010.10.006.
31. Lin C.Y., Huang C.S., Hu M.L. The use of fetal bovine serum as delivery vehicle to improve the uptake and stability of lycopene in cell culture studies. Br J Nutr 2007, 98:226-232.
32. Chuang C.H., Hu M.L. Synergistic DNA damage and lipid peroxidation in cultured human white blood cells exposed to 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone and ultraviolet A. Environ Mol Mutagen 2006, 47:73-81.
33. Song T.Y., Lin H.C., Yang N.C., Hu M.L. Antiproliferative and antimetastatic effects of the ethanolic extract of Phellinus igniarius (Linnearus: Fries) Quelet. J Ethnopharmacol 2008, 115:50-56.
34. Olefsky J.M. Nuclear receptor minireview series. J Biol Chem 2001, 276:36863-36864.
35. Kubota T., Koshizuka K., Williamson E.A., Asou H., Said J.W., Holden S., et al. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo. Cancer Res 1998, 58:3344-3352.
36. Hager M.H., Solomon K.R., Freeman M.R. The role of cholesterol in prostate cancer. Curr Opin Clin Nutr Metab Care 2006, 9:379-385.
37. Swyer G.I.M. The cholesterol content of normal and enlarged prostates. Cancer Res 1942, 2:372-375.
38. Miller N.E., La Ville A., Crook D. Direct evidence that reverse cholesterol transport is mediated by high-density lipoprotein in rabbit. Nature 1985, 314:109-111.
39. Brooks-Wilson A., Marcil M., Clee S.M., Zhang L.H., Roomp K., van Dam M., et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999, 22:336-345.
40. Hou M., Xia M., Zhu H., Wang Q., Li Y., Xiao Y., et al. Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells via PPARgamma-LXRalpha-ABCA1-dependent pathway associated with apoE. Cell Biochem Funct 2007, 25:33-44.
41. Fukuchi J., Hiipakka R.A., Kokontis J.M., Hsu S., Ko A.L., Fitzgerald M.L., et al. Androgenic suppression of ATP-binding cassette transporter A1 expression in LNCaP human prostate cancer cells. Cancer Res 2004, 64:7682-7685.
42. Chawla A., Boisvert W.A., Lee C.H., Laffitte B.A., Barak Y., Joseph S.B., et al. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell 2001, 7:161-171.
43. McCarty M.F. Current prospects for controlling cancer growth with non-cytotoxic agents - nutrients, phytochemicals, herbal extracts, and available drugs. Med Hypotheses 2001, 56:137-154.
44. Aggarwal B.B., Takada Y., Oommen O.V. From chemoprevention to chemotherapy: common targets and common goals. Expert Opin Investig Drugs 2004, 13:1327-1338.
45. Chuu C.P., Hiipakka R.A., Kokontis J.M., Fukuchi J., Chen R.Y., Liao S. Inhibition of tumor growth and progression of LNCaP prostate cancer cells in athymic mice by androgen and liver X receptor agonist. Cancer Res 2006, 66:6482-6486.
46. Young A.J., Lowe G.M. Antioxidant and prooxidant properties of carotenoids. Arch Biochem Biophys 2001, 385:20-27.
47. Palozza P. Prooxidant actions of carotenoids in biologic systems. Nutr Rev 1998, 56:257-265.
48. Palozza P., Calviello G., Serini S., Maggiano N., Lanza P., Ranelletti F.O., et al. beta-Carotene at high concentrations induces apoptosis by enhancing oxy-radical production in human adenocarcinoma cells. Free Radic Biol Med 2001, 30:1000-1007.
49. Edwards A.J., Vinyard B.T., Wiley E.R., Brown E.D., Collins J.K., Perkins-Veazie P., et al. Consumption of watermelon juice increases plasma concentrations of lycopene and beta-carotene in humans. J Nutr 2003, 133:1043-1050.
50. Horoszewicz J.S., Leong S.S., Kawinski E., Karr J.P., Rosenthal H., Chu T.M., et al. LNCaP model of human prostatic carcinoma. Cancer Res 1983, 43:1809-1818.
51. Schmidt B.M., Erdman J.W., Lila M.A. Differential effects of blueberry proanthocyanidins on androgen sensitive and insensitive human prostate cancer cell lines. Cancer Lett 2006, 231:240-246.